CytoMed Therapeutics Ltd held its annual meeting on May 15, 2024, with 6,714,256 shares present, approving all proposed resolutions including a US$90,000 director's fee for 2024. Significant decisions included the re-election of Mr. Choo Chee Kong and the appointment of independent auditors for the next financial year.